Publications

Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool

2020

de Kock, S.; Stirk, L.; Ross, J.; Duffy, S.; Noake, C.; Misso, K.

Int J Technol Assess Health Care; 37: e18.

Sacral neuromodulation for lower urinary tract and bowel dysfunction in animal models: a systematic review with focus on stimulation parameter selection

2020

Douven, P.; Assmann, R.; Breukink, S.O.; Melenhorst, J.; Kleijnen, J.; Joosten, E.A.; van Koeveringe, G.A.

Neuromodulation; 23: 1094-1107.

Stimulation parameters for sacral neuromodulation on lower urinary tract and bowel dysfunction-related clinical outcome: a systematic review

2020

Assmann, R.; Douven, P.; Kleijnen, J.; van Koeveringe, G.A.; Joosten, E.A.; Melenhorst, J.; Breukink, S.O.

Neuromodulation; 23: 1082-93.

Optimizing the use of high-sensitivity troponin assays for the early rule-out of myocardial infarction in patients presenting with chest pain: a systematic review

2020

Westwood, Marie E; Armstrong, Nigel; Worthy, Gill; Fayter, Debra; Ramaekers, Bram L T; Grimm, Sabine; Buksnys, Titas; Ross, Janine; Mills, Nicholas L; Body, Richard; Collinson, Paul O; Timmis, Adam; Kleijnen, Jos

Clin Chem; 67: 237-44.

Exercise/physical activity and health outcomes: an overview of Cochrane systematic reviews

2020

Posadzki, P.; Pieper, D.; Bajpai, R.; Makaruk, H.; Könsgen, N.; Neuhaus, A.L.; Semwal, M.

BMC Public Health; 20: 1724

Lenalidomide with rituximab for previously treated follicular lymphoma and marginal zone lymphoma: an Evidence Review Group perspective of a NICE single technology appraisal

2020

Witlox, W.J.A.; Grimm, S.E.; Riemsma, R.; Armstrong, N.; Ryder, S.; Duffy, S.; Huertas Carrera, V.; Posadzki, P.; Worthy, G.; Pouwels, X.G.L.V.; Ramaekers, B.L.T.; Kleijnen, J.; Joore, M.A.; van Asselt, A.D.I.

Pharmacoeconomics; 39: 171-80.

Standardized Protocol Items Recommendations for Observational Studies (SPIROS) for observational study protocol reporting guidelines: protocol for a Delphi study

2020

Mahajan, R.; Burza, S.; Bouter, L.M.; Sijtsma, K.; Knottnerus, A.; Kleijnen, J.; Dael, P.V.; Zeegers, M.P.

JMIR Res Protoc; 9: e17864.

Tools to help healthcare professionals recognize palliative care needs in patients with advanced heart failure: a systematic review

2020

Ament, S.M.; Couwenberg, I.M.; Boyne, J.J.; Kleijnen, J.; Stoffers, H.E.; van den Beuken, M.H.; Engels, Y.; Bellersen, L.; Janssen, D.J.

Palliat Med; 35: 45-58.

Feasibility and effectiveness of home-based therapy programmes for children with cerebral palsy: a systematic review

2020

Beckers, L.W.M.E.; Geijen, M.M.E.; Kleijnen, J.; Rameckers, E.A.A.; Schnackers, M.L.A.P.; Smeets, R.J.E.M.; Janssen-Potten, Y.J.M.

BMJ Open; 10: e035454.

Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis

2020

Armstrong, N.; Büyükkaramikli, N.; Penton, H.; Riemsma, R.; Wetzelaer, P.; Huertas Carrera, V.; Swift, S.; Drachen, T.; Raatz, H.; Ryder, S.; Shah, D.; Buksnys, T.; Worthy, G.; Duffy, S.; Al, M.; Kleijnen, J.

Health Technol Assess; 24: 1-220.

A systematic review and mixed treatment comparison of pharmaceutical interventions for multiple sclerosis

2020

Giovannoni, G.; Lang, S.; Wolff, R.; Duffy, S.; Hyde, R.; Kinter, E.; Wakeford, C.; Pia Sormani, M.; Kleijnen, J.

Neurol Ther; 9: 359-74.

Overview of differences and similarities of published mixed treatment comparisons on pharmaceutical interventions for multiple sclerosis

2020

Pia Sormani, M.; Wolff, R.; Lang, S.; Duffy, S.; Hyde, R.; Kinter, E.; Wakeford, C.; Giovannoni, G.; Kleijnen, J.

Neurol Ther; 9: 335-58.

Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review

2020

Graupner, C.; Kimman, M.L; Mul, S.; Slok, A.H.M.; Claessens, D.; Kleijnen, J.; Dirksen, C.D.; Breukink, S.O.

Support Care Cancer; 29: 573-93.

Language bias in systematic reviews: you only get out what you put in

2020

Stern, C.; Kleijnen, J.

JBI Evid Synth; 18: 1818-9.

Prognostic models for newly‐diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta‐analysis

2020

Kreuzberger, N.; Damen, J.A.A.G.; Trivella, M.; Estcourt, L.J.; Aldin, A.; Umlauff, L.; Vazquez-Montes, M.D.L.A.; Wolff, R.; Moons, K.G.; Monsef, I.; Foroutan, F.; Kreuzer, K-A.; Skoetz, N.

Cochrane Database Syst Rev: CD012022 (7).

At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR based tests? A systematic review of individual participant data

2020

Wolff, R. et al.

Cannabidiol for adjuvant treatment of seizures associated with Lennox–Gastaut Syndrome and Dravet Syndrome: an Evidence Review Group perspective of a NICE single technology appraisal

2020

Wijnen, B.; Armstrong, N.; Ramaekers, B.; Witlox, W.; Westwood, M.; Fayter, D.; Ryder, S.; Buksnys, T.; Worthy, G.; Misso, K.; Grimm, S.; Kleijnen, J.; Joore, M.

Pharmacoeconomics; 38: 1043-53.

European Society of ColoProctology: guideline for haemorrhoidal disease

2020

van Tol, R.R. ; Kleijnen, J.; Watson, A.J.M.; Jongen, J.; Altomare, D.F.; Qvist, N.; Higuero, T.; Muris, J.; Breukink, S.O.

Colorectal Dis; 22: 650-62.

Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis: an Evidence Review Group perspective of a NICE single technology appraisal

2020

Pouwels, X.G.L.V.; Petersohn, S.; Huertas Carrera, V.; Denniston, A.K.; Chalker, A.; Raatz, H.; Armstrong, N.; Shah, D.; Witlox, W.; Worthy, G.; Noake, C.; Riemsma, R.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 38: 431-41.

What tests could potentially be used for the screening, diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages? [Internet]

2020

Green, K.; Winter, A.; Dickinson, R.; Graziadio, S.; Wolff, R.; Mallett, S.; Allen, A.J.

Oxford: Centre for Evidence-Based Medicine (CEBM).

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

2020

Wynants, L.; Van Calster, B.; Collins, G.S.; Riley, R.D.; Heinze, G.; Schuit, E.; Bonten, M.M.J.; Damen, J.A.A.; Debray, T.P.A.; de Jong, V.M.T.; De Vos, M.; Dhiman, P.; Haller, M.C.; Harhay, M.O.; Henckaerts, L.; Heus, P.; Kreuzberger, N.; Lohman, A.; Luijken, K.; Ma, J.; Martin, G.P.; Andaur, C.L.; Reitsma, J.B.; Sergeant, J.C.; Shi, C.; Skoetz, N.; Smits, L.J.M.; Snell, K.I.E.; Sperrin, M.; Spijker, R.; Steyerberg, E.W.; Takada, T.; Tzoulaki, I.; van Kuijk, S.M.J.; van Royen, F.S.; Verbakel, J.Y.; Wallisch, C.; Wilkinson, J.; Wolff, R.; Hooft, L.; Moons, K.G.M.; van Smeden, M.

Edinburgh: European Society of ColoProctology (ESCP).

A systematic literature review looking for the definition of treatment burden

2020

Alsadah, A.; van Merode, T.; Alshammari, R.; Kleijnen, J.

Heliyon; 7: e03641.

Response to comment on “Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis: an Evidence Review Group perspective of a NICE single technology appraisal”

2020

Pouwels, X.G.L.V.; Petersohn, S.; Huertas Carrera, V.; Denniston, A.K.; Chalker, A.; Raatz, H.; Armstrong, N.; Shah, D.; Witlox, W.; Worthy, G.; Noake, C.; Riemsma, R.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 38: 649-51.

Durvalumab for the treatment of locally advanced, unresectable, stage III non‑small cell lung cancer: an Evidence Review Group perspective of a NICE single technology appraisal

2020

Witlox, W.J.A.; van Asselt, A.D.I.; Wolff, R.; Armstrong, N.; Worthy, G.; Chalker, A.; Buksnys, T.; Stirk, L.; Kleijnen, J.; Joore, M.A.; Grimm, S.E.

Pharmacoeconomics; 38: 317-24.